Text Size

Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light

This study has been completed.
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00432224
First received: February 6, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

The objective of the study is to evaluate the use of sunlight instead of red light during photodynamic therapy of actinic keratoses using methyl aminolevulinate


Condition Intervention
Actinic Keratoses
 Procedure: photodynamic therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 28
Study Start Date: May 2006
Estimated Study Completion Date: February 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • symmetric actinic keratoses in scalp or face

Exclusion Criteria:

  • porphyria, pregnancy, breast feeding
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00432224

Locations
Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Study Director: Hans Christian Wulf, Professor, MD Bispebjerg Hospital
Study Chair: Merete Hædersdal, MD, PhD Bispebjerg Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00432224     History of Changes
Other Study ID Numbers: KF 01-272867
Study First Received: February 6, 2007
Last Updated: February 6, 2007
Health Authority: Denmark: Danish institute of health

Additional relevant MeSH terms:
Keratosis
Keratosis, Actinic
Skin Diseases
Precancerous Conditions
Neoplasms

ClinicalTrials.gov processed this record on June 18, 2013